Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan Mcneill currently holds 159,707 shares of Dyne Therapeutics, Inc. (DYN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Mcneill has been a net seller of DYN stock. They have purchased $0 and sold $5.6M worth of shares.
Jonathan Mcneill's most recent insider trade was on Dec 15, 2025, when they sold 6,000 shares at $0.00 per share.
Jonathan Mcneill serves as Executive at Dyne Therapeutics, Inc. (DYN). They have executed 61 insider transactions totaling $5.6M over their tenure at the company.
Jonathan Mcneill holds the position of Executive at Dyne Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Jonathan Mcneill has shown a selling trading pattern, with $0 in total purchases and $5.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jonathan Mcneill was on Mar 8, 2024, when they sold $1.5M worth of DYN shares. This transaction involved 54,648 shares at $26.72 per share.
Jonathan Mcneill currently owns 159,707 shares of Dyne Therapeutics, Inc. (DYN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan Mcneill's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan Mcneill has 61 Form 4 filings on record as an insider at Dyne Therapeutics, Inc..
Set alerts for Jonathan Mcneill and 40,000+ other insiders.